Kidney Transplant Outcomes
Explore the Transplant Journey Living Donor Program Access FAQs
The Piedmont Transplant Institute is among the top 15 percent in overall transplant volumes nationally. The Transplant team continues to have excellent outcomes with graft and patient survival rates exceeding national expectations.
The correlation between our expertise and outcomes is clear. Piedmont Transplant Institute's statistics compare favorably with those of several other transplant programs in the nation.


Kidney Transplant Outcomes Data
MEDIAN TIMES FROM
WAIT-LIST TO KIDNEY TRANSPLANT:*
|
|
*Source: www.srtr.org. 7/2008 – 12/2013. |
|
1-YEAR KIDNEY TRANSPLANTS PATIENT SURVIVAL*
|
KIDNEY TRANSPLANTS by TYPE
|
Piedmont
|
Expected
|
National
|
LIVING DONOR
|
99.28
|
98.96
|
98.91
|
DECEASED DONOR
|
97.51
|
96.73
|
96.58
|
ALL DONOR TYPES
|
98.28
|
97.69
|
97.36
|
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2014 – 12/2016.
|
3-YEAR KIDNEY TRANSPLANTS PATIENT SURVIVAL*
|
KIDNEY TRANSPLANTS by TYPE
|
Piedmont
|
Expected
|
National
|
LIVING DONOR
|
95.68
|
95.66
|
96.25
|
DECEASED DONOR
|
97.51
|
96.73
|
96.58
|
ALL DONOR TYPES
|
98.28
|
97.69
|
97.36
|
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2011 – 12/2013.
|
1-YEAR KIDNEY TRANSPLANTS GRAFT SURVIVAL*
|
KIDNEY TRANSPLANTS by TYPE
|
Piedmont
|
Expected
|
National
|
LIVING DONOR
|
98.03
|
97.88
|
97.81
|
DECEASED DONOR
|
91.58
|
94.06
|
94.01
|
ALL DONOR TYPES
|
94.34
|
95.68
|
95.23
|
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2014 – 12/2016.
|
3-YEAR KIDNEY TRANSPLANTS GRAFT SURVIVAL*
|
KIDNEY TRANSPLANTS by TYPE
|
Piedmont
|
Expected
|
National
|
LIVING DONOR
|
94.80
|
92.36
|
92.93
|
DECEASED DONOR
|
89.71
|
85.16
|
86.10
|
ALL DONOR TYPES
|
92.24
|
88.74
|
88.49
|
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2011 – 12/2013.
KIDNEY TRANSPLANT DATA*
|
KIDNEY TRANSPLANTS by TYPE
|
Piedmont
|
Region
|
Nation
|
DECEASED DONOR |
82
|
1,869 |
13,841 |
LIVING DONOR |
57
|
608 |
5,722 |
TOTAL |
139
|
2,477 |
19,563 |
% LIVING DONOR |
41.0
|
24.5 |
29.2 |
*Source: www.srtr.org. Center activity 7/2016 – 6/2017. |
|
|
1-YEAR KIDNEY TRANSPLANT PATIENT SURVIVAL*
|
PATIENT SURVIVAL
|
Actual
|
Expected
|
Piedmont
|
98.28
|
97.69
|
Emory |
95.95
|
97.49
|
AUMC |
95.06
|
97.14
|
Mayo Clinic (JAX) |
95.52
|
97.18
|
Shands (UNIV FLA). |
98.65
|
97.89
|
Florida Hospital |
95.61
|
97.01
|
MUSC |
98.06
|
97.26
|
UAB |
96.78 |
97.33 |
National |
97.36
|
N/A
|
*Source: www.srtr.org. 7/2014 – 12/2016.
|
3-YEAR KIDNEY TRANSPLANT PATIENT SURVIVAL*
|
PATIENT SURVIVAL
|
Actual
|
Expected
|
Piedmont
|
94.57
|
93.71
|
Emory |
93.12
|
93.63
|
AUMC |
89.51
|
92.92
|
Mayo Clinic (JAX) |
95.10
|
93.67
|
Shands (UNIV FLA) |
90.62
|
94.33
|
Florida Hospital |
94.17
|
94.32
|
UAB |
92.04
|
93.15
|
MUSC |
93.09
|
93.35
|
National |
93.61
|
N/A
|
*Source: www.srtr.org. 7/2011 – 12/2013.
|
1-YEAR KIDNEY TRANSPLANT GRAFT SURVIVAL*
|
PATIENT SURVIVAL
|
Actual
|
Expected
|
Piedmont
|
94.34
|
95.68
|
Emory |
94.55
|
95.21
|
AUMC |
93.30
|
94.76
|
Mayo Clinic (JAX) |
92.50
|
94.72
|
Shands (UNIV FLA) |
93.55
|
95.81
|
Florida Hospital |
94.11
|
94.83
|
MUSC |
94.70 |
94.93 |
UAB |
94.92
|
95.06
|
National |
95.23
|
N/A
|
*Source: www.srtr.org. 7/2014 – 12/2016.
|
3-YEAR KIDNEY TRANSPLANT GRAFT SURVIVAL*
|
PATIENT SURVIVAL
|
Actual
|
Expected
|
Piedmont
|
92.24
|
88.74
|
Emory |
89.26
|
87.54
|
AUMC |
82.58
|
86.98
|
Mayo Clinic (JAX) |
89.08
|
88.68
|
Shands (UNIV FLA) |
86.32
|
88.59
|
Florida Hospital |
88.94
|
88.45
|
UAB |
88.91
|
87.21
|
MUSC |
85.68
|
86.85
|
National |
88.49
|
N/A
|
*Source: www.srtr.org. 7/2011 – 12/2013.
WAITING LIST MORTALITY*
|
PATIENT SURVIVAL
|
ACTUAL
|
EXPECTED
|
RATE RATIO ESTIMATE
|
Piedmont 164* |
7.6 |
13.4 |
0.58 |
Emory 199 |
20.2 |
18.0 |
1.12 |
Mayo Clinic (JAX) 98 |
11.0 |
19.9 |
0.57 |
Shands (UNIV FLA) 116 |
13.9
|
15.1 |
0.92 |
Florida Hospital 49 |
15.2
|
14.0 |
1.07 |
MUSC 48 |
27.6
|
27.6 |
1.00 |
UAB 128 |
17.4
|
17.8 |
.98 |
*Count on waiting list at start.
*Source: www.srtr.org. Center activity 7/2015 – 6/2017. |
|
For additional information on outcomes, visit the SRTR website.